Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000154999 | SCV000204681 | likely benign | not specified | 2014-12-23 | criteria provided, single submitter | clinical testing | p.Glu3692Lys in exon 45B of TTN: This variant is not expected to have clinical s ignificance due to a lack of conservation across species, including mammals. Of note, the chinchilla, bush-tailed rat, rabbit, and pika have a lysine (Lys) at t his position despite high nearby amino acid conservation. It has also been ident ified in 41/67642 European chromosomes by the Exome Aggregation Consortium (ExAC , http://exac.broadinstitute.org; dbSNP rs186624523). |
Gene |
RCV000713965 | SCV000238168 | likely benign | not provided | 2021-06-23 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000713965 | SCV000700978 | uncertain significance | not provided | 2018-05-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000619410 | SCV000736543 | likely benign | Cardiovascular phenotype | 2020-06-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics Inc | RCV000713965 | SCV000844617 | likely benign | not provided | 2018-07-05 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000769092 | SCV000900465 | uncertain significance | Cardiomyopathy | 2017-07-14 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001328736 | SCV001519921 | uncertain significance | Tibial muscular dystrophy | 2019-08-08 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Ce |
RCV000713965 | SCV004148156 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | TTN: BP1, BP4 |
Clinical Genetics, |
RCV000713965 | SCV001919966 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000713965 | SCV001964487 | uncertain significance | not provided | no assertion criteria provided | clinical testing |